A more comfortable and reliable blood-sugar monitoring system is being designed at KTH Royal Institute of Technology (KTHRInstTech) in Stockholm for people with diabetes (lat. Diabetes Mellitus). After successfully testing a prototype of a microneedle patch on a human subject, the completion of a system for clinical tests is now underway. Continuous monitoring is a way to safely and reliably lower blood glucose – giving the user a full picture of their glucose levels throughout the day and helping them avoid severe hypoglycemia. But the continuous glucose monitoring systems (known as CGMS) in use today have two main drawbacks: they are uncomfortable since they require a minimum 7mm needle that’s inserted into the skin; and, because of their size, they take measurements in the fat tissue – not the most ideal location.